Intel's 550% year-to-date surge reflects a structural narrative centered on domestic semiconductor manufacturing revival and cost advantages in advanced chip packaging relative to TSMC. Multiple Wall Street firms elevated price targets significantly in late June—Cantor Fitzgerald to $150 (67% increase) and Bank of America to $160 (18.5% increase)—citing renewed confidence in foundry economics and hyperscaler capital reallocation away from Taiwan. The dominant catalyst is Big Tech's deliberate geographic diversification of semiconductor production, amplified by government support for domestic chip manufacturing. Goldman Sachs initiated coverage with a Neutral rating and $150 target, positioning Intel as a strategic beneficiary despite binary execution risk. However, fundamental decoupling risks persist—the rally appears detached from operational improvements rather than grounded in engineering revival. Sector momentum from Micron's strong earnings and broader chip sector rebound provides tailwind. Forward implications hinge entirely on Intel's ability to execute foundry capacity scaling and capture hyperscaler volumes, with execution risk creating a wide $90-$150 valuation range reflecting structural uncertainty rather than cyclical recovery.